Quick Answer
PTC THERAPEUTICS, INC. reported Net Income of $682.64 million for fiscal year 2025.
PTC THERAPEUTICS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $682.64M | +287.9% |
| 2024 | -$363.30M | +42.0% |
| 2023 | -$626.60M | -12.1% |
| 2022 | -$559.02M | -6.7% |
| 2021 | -$523.90M | -19.6% |
| 2020 | -$438.16M | -74.2% |
| 2019 | -$251.58M | -96.4% |
| 2018 | -$128.08M | -62.1% |
| 2017 | -$79.00M | +44.4% |
| 2016 | -$142.11M | +16.6% |
| 2015 | -$170.45M | -81.8% |
| 2014 | -$93.75M | -81.8% |
| 2013 | -$51.57M | -96.6% |
| 2012 | -$26.23M | -184.9% |
| 2011 | $30.90M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $15.90M | +114.9% | +124.5% |
| June 30, 2025 | -$64.85M | +34.6% | -107.5% |
| March 31, 2025 | $866.56M | +1046.3% | +912.5% |
| September 30, 2024 | -$106.65M | +19.8% | -7.5% |
| June 30, 2024 | -$99.18M | +50.1% | -8.3% |
| March 31, 2024 | -$91.58M | +34.1% | +31.1% |
| September 30, 2023 | -$132.97M | -21.6% | +33.1% |
| June 30, 2023 | -$198.88M | -30.8% | -43.1% |
- PTC THERAPEUTICS, INC. showed an increase of +287.9% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, PTC THERAPEUTICS, INC.’s net income has grown by 2108.9% (from $30.90 million to $682.64 million).
- The most recent figure is from PTC THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: